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ABSTRACT 
SEXUAL DIMORPHISM IN PERIODONTITIS IN MOUSE MODEL 
Robert C. Gleason, B.S. 
April 19th, 2013 
 
Background: Periodontal disease is an infection-driven chronic inflammatory disease. It 
occurs primarily from excessive inflammatory reactions that arise from complex 
exchanges between the host immune system and the tooth associated oral bacteria. It is 
the number one cause of tooth loss among adults1, 2. However, many factors confound 
results between males and females as to which sex is more susceptible to periodontal 
disease. Identifying the sex more prone to disease is integral in developing models of risk 
assessment and looking into the pathogenesis. 
 
Objective: To examine in vivo and in vitro the differences between male and female mice 
challenged with Porphyromonas gingivalis. 
 
Methods: Mice were divided into four groups consisting of male ligated, male non-
ligated, female experimental ligated, and female non-ligated. All groups were given a 
ligature around the second molar. Experimental groups were administered P. gingivalis 
while the controls being non-ligated. After 7 days, mice were euthanized and bone losses 
were determined. Bone losses were measured by taking the distance from the 
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cementoenamel junction (CEJ) to the alveolar bone crest (ABC). Colony Forming Units 
(CFUs) were acquired from all groups as well. CFUs displayed bacterial clearance 
amongst the male and female mice. An oral gavage infection model was administered to 
confirm our ligature model results. Four groups were developed consisting of male 
experimentals, male sham infections, female experimentals, and female shams. From an 
in vitro perspective gingival tissue was harvested from each mouse and cytokine response 
levels were measured. Cytokine levels served as a method of looking into the immune 
system’s role in periodontal disease.   
 
Results: In comparison with male mice, female mice displayed significantly increased 
periodontal bone loss (p < 0.05) in both the ligature and oral gavage models, 
accompanied by elevated expression of pro-inflammatory cytokines. More oral bacteria 
were also detected in female mice than in males. In vitro experiments showed that 
macrophages from female mice respond to P. 
gingivalis with higher intensity. These findings along with the previously mentioned may 
contribute to more severe inflammation and bone losses in females. 
 
Conclusion: Female mice are more likely to exhibit persistent P. gingivalis infection, and 
develop higher levels of bone loss in comparison to their male counterparts. These 
occurrences differ from human studies in which males are the predominant gender for 
this disease.
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
Periodontal disease is a disease of the oral cavity that is caused by bacterial 
infection. Periodontal disease is plaque induced, and results in gingival inflammation, 
tissue destruction, and alveolar bone resorption 3-6. Alveolar bone is responsible for root 
support and stability of each tooth, and the resorption of underlying bone leads to 
eventual tooth loss 2. Periodontal disease is the leading cause of tooth loss among adults 1, 
2, and according to the University of Maryland Medical Center is estimated to afflict 75% 
of the American population in its various forms. The disease arises through a complex 
interaction between the host immune system and the oral bacteria associated within the 
mouth. Periodontal disease is associated with systemic diseases, including heart disease, 
diabetes, lung disease, and pregnancy complications 7. 
 Periodontal disease is a complex disease that is caused by collateral tissue damage 
from the pathogen-induced host immune system. The disease itself has numerous 
extraneous factors that are involved in disease susceptibility. These include stress, sex, 
age, smoking, alcohol consumption, and the above-mentioned conditions of heart disease, 
diabetes, and etc. The mechanisms of periodontal disease are intricate and much is still 






disease research by eliminating extraneous variables presented in humans. Animal 
models serve as a means for immune system examination. Specifically targeting the 
immune system’s affect on the host. 
 Gender’s role in periodontal disease is controversial. There are reports revealing 
females to be of higher susceptibility 8, 9, and conversely there are reports pointing to 
males being the sex of higher susceptibility 10, 11. These discrepancies are the 
manifestation of gender-related habits, such as smoking 12, alcohol consumption 13, and 
oral hygiene habits. Overall, in human studies males serve as the gender more susceptible 
to periodontal disease. There are exceptions to this with women being more susceptible to 
periodontal disease during pregnancy, in puberty, and in menstruation, but these are a 
different form of disease. Periodontitis in pregnant women causes premature and 
underweight deliveries 14. Furthermore, women suffer more from autoimmune diseases 
such as multiple sclerosis, rheumatoid arthritis, lupus, Hashimoto’s thyroiditis, and etc.15. 
Comprehending gender’s role in periodontal disease is ideal for developing methods of 
treatment, understanding its pathogenesis, and formulating models of risk assessment. 
Periodontal disease and Porphyromonas gingivalis 
 Initiation and progression of periodontal disease requires subgingival bacteria. 
These bacteria are found in dental plaque, and induce the periodontal host response 16, 17. 
The oral cavity is one of the most ecologically complex systems within the human body. 
Ample numbers of bacteria live within the oral cavity. It’s estimated that over 700 
bacterial species inhabit the human mouth; living on the surfaces of our teeth, cheeks, 
gums, and tongue 18 Surprisingly, the majority of the bacterial species within the oral 
cavity are common inhabitants and are not pathogens. These bacteria live in harmony 
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with the host, and are known as symbionts.  It was initially thought for disease a sole 
bacterium was responsible for its cause. A one germ, one disease paradigm served as the 
initial theory. It’s now thought that the loss of an advantageous bacterium may prove just 
as detrimental to the host, as acquiring a destructive bacterium in disease occurring 
situations. 
Dental plaque is defined as “matrix enclosed bacterial populations adherent to 
each other and to/or surfaces or interfaces”, also known as microbial biofilms 19. These 
microbial biofilms cover the surface of our teeth. This occurs by microcolonies of 
bacteria secreting a sticky substance responsible for bacterial adherence. This sticky, 
glue-like substance is composed of polymers like proteins, nucleic acids, and 
polysaccharides. 
Two types of biofilms are present within the oral cavity. Supragingival plaque 
inhabits the area above the gingival margin, and subgingival plaque is found below the 
gingival crevice (the space between the tooth and gingival tissue) 6. Supragingival plaque 
is subject to more oral abrasions and saliva flow, which possess defensive components, in 
comparison to subgingival plaque. Subgingival plaque lives within a protected 
environment. An environment that is more conducive to growth, for the organisms are 
protected from the outside forces of saliva and oral abrasions. There are, however, 
components that limit the growth of subgingival plaque which include space and the 
innate immune system. As subgingival plaque increases, so too does its available space. 
The biofilm growth results in an increase in the gingival sulcus pocket and epithelial cell 
attachment loss 20. 
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To survive and grow within its niche, pathogenic bacteria need the proper 
nutrients and subversion methods, such as virulence factors, for eluding the host immune 
system 21. Research has shown the virulent factors of P. gingivalis include LPS, fimbriae, 
and gingipains 22. The host immune system, which resembles a surveillance system, 
identifies and locates foreign pathogens that are detrimental to the host. It then uses 
counter-attack measures to deter the invasive pathogens. Bacteria must evade defensive 
measures present in the oral cavity for survival. Porphyromonas gingivalis (P. 
gingivalis), within the gingival sulcus, interacts with the host immune system, and takes 
extreme measures in avoiding detection 4, 23. 
According to the American Academy of Periodontology, there are various forms 
of periodontal disease. The different forms of periodontitis include aggressive 
periodontitis, chronic periodontitis.  These two forms of periodontal disease are identical 
in many clinical aspects. Both chronic and aggressive periodontitis manifest from plaque 
formation lying at and below tooth surfaces of susceptible hosts. Furthermore, the oral 
microbes that make up the plaque biofilm within the mouth are comprised of indigenous 
host organisms. The physical effects of chronic and aggressive periodontal disease are a 
result of a host’s immune and inflammatory responses 24. Differences between chronic 
and aggressive periodontitis include age of onset, progression rates, patterns of 
destruction, inflammation characteristics, and plaque and calculus abundance within the 
host. Combinations of these aforementioned characteristics classify individuals into three 
forms of periodontal disease, which are chronic periodontitis, localized aggressive 
periodontitis, and generalized aggressive periodontitis 24. 
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The progression of chronic periodontal disease symptoms is slow and the patients 
tend to be older. Aggressive periodontitis consists of two forms that are considered two 
different diseases. Localized and generalized aggressive periodontitis are discrete from 
one another. The localized form tends to have minimal signs of inflammation and a thin 
layer of plaque formation around infected teeth. Contrarily, intensive inflammation and 
high levels of biofilm formation mark generalized aggressive periodontitis. These two 
forms of aggressive periodontitis typically affect juveniles and result in rapid levels of 
development 24. Rates of progression for aggressive periodontal diseases are estimated to 
be 3 to 4 times that of chronic periodontal disease 25. 
The host response is able to clear or control bacteria, as well as cause collateral 
tissue destruction 26, 27. Immune cells such as neutrophils, macrophages, T cells are able 
to produce pro-inflammatory cytokines, which are a causative agent for periodontal 
disease. Pro-inflammatory cytokines lead to bone resorption by disrupting the balance 
between osteoblasts and osteoclast cell types. Equilibrium between these cell types must 
be achieved for healthy bone levels to occur. Infiltration of T cells, macrophages to the 
site of infection and, or the presence of TNF-α serve as indicator of chronic periodontal 
disease.  The host response is extremely complex and involves both innate immunity and 
adaptive immunity. These immune cells promote inflammation and osteoclast production, 
which ultimately leads to the final stage of periodontal disease, bone loss. 
Porphyromonas gingivalis is found in dental biofilms; it is believed to one of the most 
important etiological pathogens causing inflammation and tissue destruction in 
periodontal disease. P. gingivalis is a non-motile, gram-negative, rod shaped, anaerobic 
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pathogenic bacterium. P. gingivalis can be found in periodontal disease lesions and is 
able to induce periodontal disease in animal models 28.  
P. gingivalis is one of the bacteria in the “red” complex noted by Socransky et. al, 
1998. The species of the “red” complex, include Porphyromonas gingivalis, Tannerella 
forsythia, and Treponema denticola, all showed strong detection with one another, and 
were discovered in periodontal locations 29. P. gingivalis is also described as a keystone 
pathogen that serves a fundamental role in the structural maintenance of microbial 
community 2. Without P. gingivalis, the oral community would not break into pieces, but 
rather the pathogenicity would be altered, as well as its ability to cause periodontal 
disease 30.  This bacterial pathogen is now recognized as opportunistic pathogen within 
the oral cavity. It is capable of host cross-talk between Toll Like Receptor 2 (TLR2) and 
CXCR4 (a chemokine receptor) due to its fimbriae31. The fimbrae bind to CXCR4, which 
initiates cross talk between the CXCR4 receptors and TLR 2 receptors. Ultimately, this 
signaling causes inhibition of pro- and anti-inflammatory cytokines.  This allows for 
immune system’s defensive measures to be repressed, and provides an environment for P. 
gingivalis to thrive. This survival strategy prolongs life for of the pathogen and provides 
an opportunity for growth and success, an opportunity for the pathogen to find its niche. 
The niche for P. gingivalis occurs within the periodontal pocket of the host, and is known 
as the gingival sulcus 22. 
During progression of chronic periodontal disease, P. gingivalis undermines host 
immunity to facilitate its colonization and invasion. To establish a chronic infection, P. 
gingivalis develops strategies to evade or subvert host immunity. Its virulent factors 
possess the ability to manipulate the host response. Toll-like receptors (TLRs) are a 
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family of pattern-recognition receptors (PRRs) that recognize conserved microbial 
structures microbe- associated molecular patterns (MAMPs). LPS, lipopolysaccharides, 
from P. gingivalis contains atypical lipid A structures and signals through Toll-like 
receptor (TLR) 2 32. This is different from E. coli LPS. A study one P. gingivalis and E. 
coli LPs, revealed P. gingivalis LPS induced lower E-selectin expression on neutrophils 
than E. coli LPS 33, resulting in inefficient recruitment of neutrophils to site of infection. 
In macrophage, P. gingivalis LPS weakens TLR signaling by upregulating IRAK-M, a 
negative regulator of TLR signaling 34.  Virulence factors like gingipains are able to 
degrade TLR and cytokines 35. Fimbriae from LPS binds to CXCR4 and instigates a 
crosstalk between CXCR4 and TLR2, resulting in the suppressed P. gingivalis clearance 
36. With the well-developed evasion strategies, P. gingivalis is able to survive the hostile 
host environment and causes chronic infection. The chronic infection with P. gingivalis 
and other associated pathogens results in initial stages of inhibited immune response, 
followed by persistent inflammation leading ultimately to alveolar bone loss. 
Immune System Recognition 
Although oral pathogens initiate periodontal disease, unregulated host immune 
responses cause the inflammation, resulting in collateral tissue damage and bone loss. 
There are two types of defense within jawed mammals. They are innate and adaptive 
immunity, the latter of which is also known as acquired immunity. The innate component 
is mediated by pattern recognition receptors (PRRs).  These pattern-recognition receptors 
are transmembrane proteins which detect unique structures pertaining to a pathogen, 
known as pathogen-associated molecular patterns (PAMPs) 37, 38. PAMPs of 
microorganisms include LPS, peptidoglycan, and lipoproteins 38. 
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Macrophages are one of the most important innate immune cells, and have a 
major role in host defense 39. They have been found in periodontal diseased sites, and are 
associated with tissue resolution and homeostasis 40. The functions of macrophages 
include eliminating invading bacteria, cell recruitment to infected sites, the removal of 
the surplus of neutrophils, cytokine and chemokine synthesis, and lymphocyte mediated 
adaptive immune response40.  Like other immune cells, macrophages express PRRs and 
recognize PAMPs on pathogens 41.  
Toll-like receptors (TLRs) identify friend from foe in the host system 42.Toll like 
receptors are key to a host’s defenses. The periodontium (the tissues that surround the 
teeth, which are critical to tooth support) are constantly exposed to pathogens through 
dental plaque. Toll-like receptors are present in periodontal tissue, providing a 
countermeasure to the microbes attack. The TLRs serve as a defensive measure in 
maintaining healthy periodontal tissue 37, 38. TLRs are typically found in the first line of 
cells, the defensive cells (the neutrophils, macrophages, and dendritic cells). These 
aforementioned cells express different TLRs, which present various forms of attack on 
the invasive organisms. Neutrophils for instance, are the first cells to respond. The 
neutrophils migrate to the infected site and initiate TLR response. Signaling through 
TLRs induces the production of proteins such as cytokines, chemokines, and 
antimicrobial peptides 39.Additionally, TLRs mediate phagocytosis and cell death, by 
initiating inflammation, apoptosis, and host immune responses. Signaling through TLRs 
enhances macrophages to protect against pathogenic microbes. However, pathogens have 
also developed means of deception, which deter macrophages from clearance of 
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microbes. These tactics allow pathogens to sneak under the radar and avoid detection by 
the host’s macrophages 21. 
 
Inflammation in Periodontal disease 
Development of periodontal disease is dependent on host’s immunological 
response to bacterial infection and colonization. Inflammation, a form of immunological 
response, is a host’s physical reaction to injury 1, 39. The body’s inflammatory responses 
can be short (acute), and, or long term (chronic). The characteristics of inflammation 
include redness, swelling, pain, heat, and loss of function. 
There are two forms of inflammation, of mention, in the oral cavity that affect the 
health of the teeth and supporting structures. Both of which are marked by the acquisition 
of bacteria leading to cell infiltration 43. Gingivitis is the form of inflammation that is 
marked by the redness of gums, and is usually resolved by brushing and proper oral 
hygiene. Gingivitis affects the soft tissues and epithelium. Gingivitis that’s left untreated 
may then progresses to periodontitis. Chronic periodontal disease affects the soft tissue, 
the epithelium, and alveolar bone 44. The consequences of periodontal disease ensue by 
bacteria buildup below the tooth surface, which leads to inflammatory response via the 
immune system. Leukocytes penetrate the area and inhibit the amount of bacterial 
invasion. Factors such as bacterial products, cytokines, and cross talk between adaptive 
and innate immunity all serve as signals for leukocyte recruitment 45. 
A hosts’ response system and its relationship to periodontal disease is complex. 
Evidence points to periodontal destruction occurring as a result of deficient host 
response; conversely, studies find periodontal destruction occurring from a strong 
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immune response system as well. Furthermore, a paradigm of the protective vs. 
destructive role of the immune system comes into effect. At what stage is the immune 
system playing a protective role for the host, and when does that shift from a protective 
role to a destructive role occur? When does the immune system do more harm for the 
host than good? 
Cytokines are small proteins that serve as messengers between cells, and their 
main function is the coordination of the immune responses. Cytokines are responsible for 










Periodontology, 2000 46 
 
Figure 1. A diagram depiction of how cytokines regulate immune responses in the 
presence of a biofilm. The cytokine response to plaque biofilms results in a primary 
cytokine response from macrophages, endothelial cells, and others. These responding 
cytokines produce a cascade of signals. The signals lead to neutrophils migrating to the 
site of infection and mediated forms of immunity being initiated. 
 
The interleukin-1 (IL-1) family consists of 11 members including IL-1 alpha and 
IL-1 beta. This family is produced in single peptides, while other interleukins typically 
are found as homodimers or heterodimers. IL-1 cytokine transcription occurs by way of a 
host of pro-inflammatory mediators such as pathogen associated molecular patterns 
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(PAMPs), lipopolysaccharides (LPS), and tumor necrosis factors (TNFs)46. IL-1 family 
plays an integral role in the host immune and inflammatory response systems, this 
interleukin family is responsible for the production of additional cell mediators, like 
cytokines and chemokines. Over expression of IL-1, or the inhibition of IL-1 expression, 
results in tissue destruction. For this reason, the IL-1 has been of interest and 
investigation in periodontal research, as well as its response to the bacterium 
Porphyromonas gingivalis. The IL-1 cytokine of particular interest in this study is IL-1 β. 
IL-1 β is identified as a fundamental player in immune response and immune-mediated 
diseases. IL-1 β has a unique role within periodontal disease. Rather than having a direct 
effect on cells and tissue, it serves as the initiator of synthesis and expression of other 
crucial cell mediators 46. 
The tumor necrosis family (TNF) refers to two associated proteins, which are 
TNF- alpha (TNF-α) and TNF-beta (TNF-β) 47. The cytokine of interest in our studies is 
TNF-α. TNF-α is a primary, pro-inflammatory cytokine that is produced largely by 
macrophages and periodontal resident cells. It is produced early on by the innate immune 
system in response to the bacterial invasion. This cytokine can persist and or even 
intensify inflammation by cellular cascade signals such as matrix metalloproteinases 
(MMPs) that are key signals in the matrix disruption and bone degradation 46, 48. 
Furthermore, TNF-α is known to increase activity of phagocytes like neutrophils, and 
limits tissue repair via fibroblast apoptosis 46. 
Studies using animal models have identified TNF-α to be an integral cytokine in 
periodontitis. A mouse study was conducted in which mice that lacked TNF-α were 
found to be more susceptible to infections 47. Other studies involving mice have identified 
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external forms of TNF-α to support periodontitis 49; while the inhibition 50 of TNF-α or 
signaling failures 51 result in destructive periodontal disease. 
 
Bone Resorption 
Alveolar bone serves as the tooth stabilizer, by holding the root in place. The 
alveolar bone infrastructure is dependent on the ratio between two specific cell types. 
These cell types are known as osteoblasts and osteoclasts 3, 52. Osteoblasts are responsible 
for bone formation, and osteoclasts are responsible for resorption of bone. To maintain 
healthy bone levels, equilibrium must be achieved between osteoclasts and osteoblasts, or 
a ratio of one to one correspondingly. The imbalance of osteoclasts to osteoblasts results 
in periodontal disease. 
The mechanism involved in osteoclast cell activity is defined as the RANK/ 
RANKL system. RANK (receptor activator of nuclear factor-κB), RANKL (RANK’s 
ligand), and the soluble counterpart to RANK/RANKL is OPG (osteoprotegerin), all play 
valuable roles in the equilibrium between osteoblasts and osteoclasts. Here’s how it 
works. The ligand, RANKL, binds to its receptor, RANK, which is present on the surface 
of pre-osteoclasts. This ligand is integral to the growth, maturation, and activation of 
osteoclasts. Conversely, OPG acts like a decoy receptor, by disrupting or inhibiting 
osteoclast formation. Ultimately, the ratio between RANKL and OPG determines the 
outcome for osteolytic activity and alveolar bone 2, 3. It’s believed that one of the main 
factors in inflammation-induced bone loss is the disruption in equilibrium between 
osteoblasts and osteoclasts. The two major interactions responsible for this come from 1) 
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toll-like receptors and inflammation induced osteoclastogenesis, and 2) and cytokines and 
inflammation-induced osteoclastogenesis 52. 
 
Gender as Risk Factor in Periodontal disease 
Risk factors are described as attributes or incidences linked with an increased rate 
of disease. They are noted for being associated with an increased rate of disease, but do 
not cause the disease itself. Risk factors are divided into modifiable and non-modifiable 
risk factors. Modifiable risk factors are behavioral and environmental factors. Non-
modifiable factors are also known as determinants. They can’t be modified or changed 53, 
54. There are numerous factors that influence disease in humans. These include overall 
health, oral hygiene, alcohol consumption, and smoking. Gender, however, has been a 
controversial factor in periodontal studies. Studies remain inconclusive as to the gender 
more prone to periodontal disease; extraneous variables confound results, and make it 
difficult to ascertain which gender is truly more susceptible.  Sexual dimorphisms are 
physical differences between males and females. Identifying the sexual dimorphisms of 
periodontal disease is critical in risk assessment, to identify the sex that is more 
susceptible to disease.  
Multiple factors determine periodontal disease occurrence and the gender factor is 
a major one in affecting disease development.  It is reported that gingivitis affects 65-
75% of pregnant women 55. Moreover, women in ovulation and pre-menstruation phase 
are more prone to acquired periodontal diseases 56. Ovulation induction by clomiphene 
citrate is able to induce gingival inflammation in women 57. Exacerbated periodontal 
disease is also one of the side effects of some oral contraceptives. Surveys showed 
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contradictory results about the susceptibility to periodontal diseases in male and female 
population. Among all the periodontal office visits three quarters of those are made by 
women. This is despite the fact that women take better care of their teeth. On the other 
hand, national surveys in the USA indicated that the disease is more prevalent in men 
than in women. Studies have provided epidemiological evidence identifying males to be 
the gender more likely to develop destructive periodontal disease58. Despite the previous 
statement, men do not seem at higher risk for rapid periodontal destruction in comparison 
to their female counterparts58. Habits such as smoking 12, alcohol consumption 13, and bad 
oral hygiene habit, raise risks for periodontal disease occurrence. The dissimilarity in 
behaviors between females and males 59 interferes with the survey results and render it 
difficult to clarify the different biological responses to pathogen stimulation in females 
and males. Therefore, animal periodontal disease models are useful tools for evaluating 
the role that sex hormones play in periodontal disease pathogenesis. 
Besides the discrepancy of disease prevalence among different sexes, periodontal 
disease is more rampant in pregnant women. Periodontal disease during pregnancy can 
cause serious problem such as preterm and underweight birth 14. Interestingly, with 
enormous reports indicating higher incidences of periodontal diseases during pregnancy 
and its possible manifestations, as well as the cases of periodontal disease associated with 
puberty and menstrual cycle, studies on the working mechanisms of periodontal disease 
etiology are far from satisfactory 60. During pregnancy, estrogen is elevated to reach 
plasma level of 6 ng/ml, which is as much as three times of the normal amount up to the 
end of the third trimester. The effect of estrogen on other diseases may cast light on its 
role in periodontal disease. Women are more susceptible to develop some autoimmune 
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diseases, such as multiple sclerosis, rheumatoid arthritis (RA), systemic lupus 
erythematosus, Hashimoto’s thyroiditis, etc 61. 
 
Animal Models for Periodontal Studies 
Limitations arise from human studies. Extraneous variables such as smoking, 
alcohol consumption, oral hygiene, diabetes, overall health, stress, hormones, and gender 
are all compounding variables in studying diseases. Animal models are beneficial in 
eliminating factors such as these. Benefits of animal studies are that they are relatively 
inexpensive, they are easier to monitor and control, and they provide a definitive analysis 
for cause and effect relationships, which are difficult to ascertain in human clinical 
studies. Sadly, no single animal model mimics all aspects of human periodontal disease. 
Animal models, like human models, prove to be disadvantageous in experimental studies. 
So why use animal models? They serve as a useful model in human phenomena. They 
shed insight into aspects of the human body, in our case- immune response, that prove 
difficult from human studies. Various animal models have been used in periodontal 
studies ranging from invertebrates like Drosophila melanogaster 62, to vertebrates like 
non-human primates, dogs, and rodents. Animal models provide insight into the steps of 
periodontal disease, including 1) colonization of bacteria, 2) invasion of the bacterium 
from the epithelium into the connective tissue, 3) initiating the inflammatory system, 4) 
breakdown of the connective tissue, and 5) lastly damage control by the host and bone 
loss 63, 64. 
Rodent models are common models in the study of periodontitis because they are 
easy to handle and relatively inexpensive. Mouse models are especially important due to 
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the large number of transgenic mice and mice with genetic depletions 64. Different mouse 
models have been used to investigate etiological pathogens, host responses to pathogens, 
and host modification during the disease progression. An oral gavage model has widely 
been used as an experimental periodontitis model, in which periodontitis can been 
induced by orally infecting mice with oral pathogens such as P. gingivalis, A. 
actinomycetemcomitans, Tannerella forsythia, and etc.65 66. 
Another animal model for periodontal disease, the ligature model, is the 
placement of ligatures around teeth, which initiates periodontal tissue loss. The ligature 
leads to greater accumulation and colonization of oral pathogens, facilitating their 
invasion of connective tissue. Although this model was once commonly used with non-
human primates, interest in the rat and mouse ligature model has been boosted because it 














Table 1. Animal Models: Advantages and disadvantages of select animal models for 






Similar dental structure, microflora, 
and disease to humans'. Natural or 
experimentally induced 
periodontitis. 
Very expensive, with ethical and 
husbandry issues 
Dogs Develop natural or experimental 
periodontitis similar to humans 
Relatively expensive, need special 
daily care, husbandry issues. 
Dentition different from humans. 
Miniature 
pigs 
Dental structure and periodontitis 
have some similarity to humans'. 
Natural or experimentally induced 
periodontitis. 
Relatively expensive, husbandry 
issues; relatively few studies 
Ferrets Naturally or experimentally induced 
disease with similarity to humans' 
Some husbandry issues 
Rodents Experimentally induced disease. 
Similar molar structure to humans'. 
Inexpensive model 
Different microbiota from humans'. 
Small size and therefore amount of 
tissue for analysis. Large number of 
animals needed 









STATEMENT OF OBJECTIVES AND HYPOTHESIS 
Study Objectives 
The aim of this research was to investigate the role of gender in periodontal 
disease by using animal models. The results in human studies of periodontal disease have 
been confounded by many other risk factors such as smoking, alcohol consumption, 
stress, and disease. These factors make it difficult to determine which gender is more 
prone to periodontal disease. Developing an animal model is beneficial in eliminating 
extraneous variables that the human model present. Animal models allow us to examine 
the immune system’s effects on a host during periodontal disease. They provide insight 
into this disease where ethical issues arise from human studies. Specifically, experiments 
can be induced into animal models to study cause and effect relationships. 
 
The specific aims of this study were: 
1. To develop an animal model for periodontal study, and determine the gender 
more prone to periodontal disease. 
2. To examine pro and anti-inflammatory response in the presence of 
Porphyromonas gingivalis. 
Study Hypothesis 
Our Hypothesis is that:
  
 




1) Gender is a risk factor for periodontitis, and males are the more likely to develop 
disease. 








MATERIALS AND METHODS 
 
Reagents, bacteria, and mice: 
  
P. gingivalis ATCC 33277 were grown anaerobically from frozen stocks on 
modified Gifu anaerobic medium-based blood agar plates for 5–6 days at 37°C, followed 
by anaerobic subculturing for 18–24 hours at 37°C in modified Gifu anaerobic medium 
broth (Nissui Pharmaceutical).  This particular strain of P. gingivalis was used because of 
its known ability to induce periodontal disease. This strain has been used widely 
throughout periodontal research. Bacteria were harvested by centrifugation at 4000 rpm 
for 30 min. The cells were then washed with PBS (phosphate –buffered saline), 
suspended and determined for the final concentration using a spectrophotometer. The 
final concentration of bacteria (CFU) was standardized by using the Optical Density 
(OD) at 600 nm of 1.0, which is corresponding to 5 x108 CFU/ml. 
 
Cell culture and Assays: 
Thioglycollate-elicited macrophages were isolated from the peritoneal cavity of 
C57B/L6 mice, purchased form Jackson lab (4, 8), in compliance with established 
institutional policies and federal guidelines. These macrophages were used for several 
reasons: first, they were easy to access for harvesting; secondly, the peritoneal cavity is 






for macrophage studies70. The macrophages were cultured at 37°C and 5% CO2 in RPMI 
1640 (Invitrogen) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 100 
U/ml penicillin G, 100 µg/ml streptomycin, and 0.05 mM 2-ME. None of the 
experimental treatments affected cell viability (monitored by the CellTiter-Blue assay; 
Promega) compared with medium-only treatments. The phenotypic
characterization of peritoneal macrophages and determination of TLR2 upregulation in 
activated macrophages were performed by flow cytometric analysis, using the 
FACSCalibur and the CellQuest software (Becton–Dickinson). For these experiments, we 
used fluorescently labeled monoclonal antibodies to TLR2, followed by washing and 
flow cytometry. Our lab looked specifically at TLR2 because of its agonistic role in P. 
gingivalis. 
Cytokine production (Il-6 and IL-1β) in cell culture supernatants was determined 
by the use of ELISA. Corning Costar 9018 ELISA plates were coated with 100 micro-
liter/ well of capture antibody in Coating Buffer 4oC for overnight. The wells were 
washed 5 times with Wash Buffer the next day. Next, the wells were then blocked with 
200 micro-liter/well of 1X Assay Diluent at room temperature for 1 hour. Aspirated/ 
washed for a total of 5 washes. Next, 100 micro-liters/ well of sample was incubated in 
the appropriate wells at room temperature for 2 hours. After wash, 100 micro-liter/ well 
of detection antibody diluted in 1X Assay Diluent was added to the corresponding wells 
and incubated at room temperature for 1 hr, followed by washing and adding Avidin-
HRP for 30 minutes. After thoroughly wash, substrate solution TMB were added and 
incubated at room temperature for 15 minutes. Thereafter, 50 micro-liters of Stop 
Solution was added and the plate was read at 450 nm. 
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In vivo mouse studies: 
Ligature-induced periodontitis model: 
Periodontal inflammation and bone loss in this model is induced by a 5-0 silk 
ligature tied around the maxillary left second molar, with the ligature placed in the 
gingival sulcus.  P. gingivalis (2 x109  cells) was administered three separate times to the 
ligature sites. On the first, third, and fifth day of the experiment. The contralateral molar 
tooth in each mouse was left unligated (baseline control). Inflammatory bone loss was 
examined 7 days after placement of the ligatures, which remained in place in all mice 
during the experimental period. Bones were measured for the distance from cement-
enamel junction to alveolar bone crest (CEJ/ABC) with the VIA-170K system. 
 
 




Oral Gavage Model: 
The P. gingivalis-induced periodontal bone loss model was used essentially as 




 previously described (20). In brief, following on suppression of the normal oral flora 
with antibiotics (sulfamethoxazole/trimethoprim) in deionized water for 10 days, 10- to 
12-wk-old mice were infected by oral gavage five times at 2-d intervals with 109 CFU P. 
gingivalis suspended in 2% carboxymethylcellulose. Sham-infected control animals 
received 2% carboxymethylcellulose alone. The mice were euthanized 6 weeks later, and 
assessment of periodontal bone loss in defleshed maxillae was performed under a 
dissecting microscope (×40) fitted with a video image marker measurement system (VIA-
170K; Fryer). Specifically, the distance from the cementoenamel junction (CEJ) to the 
alveolar bone crest (ABC) was measured on 14 predetermined points on the buccal 
surfaces of the maxillary molars. The 14-site total CEJ-ABC distance for each mouse was 
subtracted from the mean CEJ-ABC distance of sham-infected mice to calculate bone 
loss. The results were expressed in millimeters, and negative values indicate bone loss 
relative to sham-infected control mice. 
All animal protocols were approved by the Institutional Animal Care and Use 
Committee in compliance with established federal and state policies. 
 
 
Figure 3: Schematic depiction of the protocol for periodontitis induction in oral gavage 
model. 
Alveolar Bone Loss Reading: 
 The mice heads were autoclaved in water (121oC for 10 minutes) and defleshed 




peroxide (H2O2) overnight. The mice heads were pulsed in 1% bleach for one minute. 
The heads received a staining using 1.0% methylene blue and 0.5% eosin dyes. 
Following, the heads were placed in the eosin dye for 5 minutes and methylene blue for 1 
minute. The heads were washed well and allowed to air dry. The bone loss measurements 
from the maxillary jaws were measured using a dissection microscope (x40) fitted with a 
video image marker measurement system (model VIA 170; Boeckeler Instruments, Inc., 
Tucson, Ariz.), millimeters is the standardized value. Seven sites on the buccal side were 
measured for the left and right molars, for a total of 14 sites. The distances were 
measured from the cemento enamel junction (CEJ) to the alveolar bone crest (ABC). The 
amount of change in the alveolar bone for each mouse was calculated by subtracting the 
CEJ to ABC distance for that mouse, from the average CEJ-ABC distance of the sham- 
infected mice.








Figure 4. Depiction of how bone loss measurements were derived.
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Determining the Total Number of Anaerobic Bacteria: 
A sterile medium sized paper point was inserted along the gum line of the upper 
molars in the murine models. The paper point was held in place for approximately 30 
seconds and then vortexed in 1 mL of prereduced brain heart infusion broth with the add-
ins of hemin and menadione. The sample was vortexed for approximately 30 seconds. 
Next 50 micro-liters of broth was acquired and plated on blood agar. The plates were 
given two weeks to culture in an anaerobic chamber before being counted. The colonies 
were counted based on the number of black-pigmented colonies. 
 
Gingival Inflammation Determination: 
The gingival tissue was harvested from the upper jaw around the molars. A small 
segment of tissue was gathered after euthanasia from each mouse. A segment of tissue 
was obtained from both the left and right sides. The left side corresponded to the infected 
site, and the right corresponded to the uninfected location. The gingival tissues were 
placed in RNAlater (Ambion Cat #AM7020) and kept at -20 oC until used for RNA 
isolation. RNA was isolated from the tissue using an RNeasy mini kit (Qiagen 
Cat#74104). Each gingival tissue was homogenized in 600 µL solution of RLT buffer and 
β-mercaptoethanol. The lysates were centrifuged for 3 minutes at full speed (14,000 
RPM) at 4 oC. The supernatant was pipetted into a new tube.  Six hundred microlitters of 
70% ethanol were added to the lysates and mixed by pipetting to ensure homogeneity. 
700 µL of sample were transferred to an RNeasy spin column placed in a 2 mL collection 
tube. The samples were centrifuged for 1 minute at 10,000 RPM. The flow through was 
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discarded. If the samples exceed 700 µL, then the step was repeated. 350 µL of RW1 
buffer was placed into each spin column for washing. The samples were then centrifuged 
for 1 minute. Next a solution of DNase and RDD buffer was added to each sample. A 
ratio of 70 µL to 10 µL or RDD buffer to DNase respectively, per sample. The DNase I 
incubation mix (DNase and RDD buffer mixture) was placed into each spin column and 
allowed to sit for 15 minutes. Another 350 µL of RW1 buffer was placed into each 
column and centrifuged for 1 minute. Next, 500 µL of RPE buffer was added to the spin 
column. RPE is supplied as a concentrate and therefore ethanol must be added to the 
buffer before using. The samples were centrifuged for 1 minute following the RPE 
buffer. Another 500 µL of RPE buffer was placed into each spin column and this time 
centrifuged for 2 minutes. Each sample was placed into a new 2 mL collection tube and 
the old tubes were discarded. The samples were then centrifuged for 1 minute. The 
samples in the spin columns were placed into a new 1.5 mL tube and 50 µL of RNase-
free water were added to each. The samples were centrifuged for 1 minute. Based on 
concentrations of RNA determined by NanoDrop, samples were converted into cDNA via 
reverse transcription. The High Capacity cDNA Reverse Transcription Kit from Applied 
Biosystems was used. The following reagent mixture was used. 
Reagents Amount (µL)- per sample 
10x Buffer 10 
25xdNTP 4 
10x Random Primers 10 
RT 5 
RNase Inhibitor 5 
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DEPC H2O 16 
Total 50 
Table 2. Reagent mixture required for Reverse Transcriptase. 
40ng of RNA in 50 µL of DEPC H2O was transferred into each tube while 
remaining on ice. Next, 50 µL of reagent mixture was transferred into each tube. The 
samples were then centrifuged. The PCR machine was placed on the rt2 setting. The 
protocol was then run at the desired volume of 100 µL. 
 
Real Time PCR: 
 The cDNA samples were taken from the freezer and allowed to thaw on ice. A 
mixture of 100 µL sample, 980 µL Ultra Pure Water and 1080 µL Taqman Master Mix 
were placed used for a total volume of 2,160 µL. The tubules were capped and vortexed 
to mix the samples completely. The samples were then centrifuged. The qPCR plate was 
prepared for the experiment by removing the plate cover, and centrifuging the plate at 
10,000 RPM for 1 minute. Next the cover of the plate was removed and 20 µL of mix 
(cDNA plus master mix) was placed into each well. The plate was then centrifuged again. 
The plate was then run using the qPCR machine and 7500 software. A plate template was 
developed for the experiment. 
 
Statistical analysis: 
Data were evaluated by analysis of variance and the Tukey–Kramer Multiple 
Comparisons Test using the InStat program (GraphPad Software, San Diego, CA). Where 
appropriate (comparison of two groups only), two-tailed t tests were performed. P < 0.05 
was taken as the level of significance.




More severe periodontitis in females in the Ligature Experiment: 
 To identify the role of gender differences in periodontitis with the exclusion of 
other behavior-related risk factors, we investigated the periodontal phenotype of female 
and male mice in a ligature-induced periodontitis model, which was mentioned in 
materials and methods. Female and male C57BL/ 6 mice were ligated around 2nd molars 
and infected with live P. gingivalis. The mice were infected with P.gingivalis every other 
day for a total of three infections. The controls were sham-ligated and sham-infected 
mice (non-ligated). Eight days later, mouse jaw bones were obtained and measured for 
the distance between the cemento-enamel junction and alveolar bone crest of each molar 
(3 molars on both sides) in the mouse cavity. We found that both female and male ligated 
mice showed significantly greater CEJ-ABC readings than the non-ligated controls, while 
female ligated mice showed higher levels of CEJ-ABC reading in comparison to the male 
ligated group (Figure 5). Both the female and male non-ligated groups, the control 
groups, were of equal values in bone loss, which served as an indication to a true control 
group being established. Our results indicated that female mice are more susceptible to 
bone loss in the P. gingivalis ligature model.  
Inflammation is able to induce alveolar bone loss and is also indication of 
periodontitis. In order to determine the severity of periodontitis, we tested gingival 
inflammation in female and male mice. IL-1, IL-6, and TNF have been well known for  
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their presence in periodontitis patients and their detrimental function in periodontal 
disease and bone loss 71. Analysis of the periodontal inflammatory response by real-time 
quantitative PCR showed differences in certain periodontitis-related pro-inflammatory 
cytokines between female and male mice. We observed significant higher upregulation in 
the expression of IL-1 and IL-6 in females, which are critical in periodontitis progression 
(Fig. 6). Although not significant, TNF expression was also upregulated in female in 
higher level. IL-17 is an important pro-inflammatory cytokine, which is paid more 
attention due to its tight link to newly found Th17 cells. Our recent publication showed 
that IL-17 caused more severe periodontitis72. In Fig. 6, ligated female mice expressed 
higher IL-17 compared to their male counterparts. On the other hand, the expression of 
anti-inflammatory cytokines IL-10 and TGF did not show difference in female and male 
gingival tissues (Fig 6), implying that more gingival inflammation in females caused 
more severe periodontitis.  
 Because oral pathogens are responsible for initiating and progressing 
periodontitis, anaerobic colony forming units (CFUs) within the oral cavities of male or 
female mice were examined (Figure 7). Before the ligation, oral bacteria of the males and 
females were determined for the baseline. The oral bacteria of pre-ligation mice are 
essentially equal in colony forming units. Eight days after ligation, we found that  
female mice had a much greater bacterial burden than that of their counterpart male mice, 
which suggested the involvement of bacteria in this bone-loss model (Fig. 5). More 
bacterial burden in female mice may be due to lower clearance ability of female mice. 
Another possibility is that higher inflammation in female mice provides more nutrients 
and optimal environment for the survival of oral bacteria. In summary, female mice 
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showed higher alveolar bone loss, gingival inflammation, and a greater bacterial burden 
within the oral cavity, which indicated female mice were more prone to more severe 
periodontitis, at least in ligature-induced periodontitis animal model.  
 
Bone loss in female and male mice in an oral gavage model: 
 To determine whether our observations of female mice developing more severe 
periodontitis was specific to the ligature model, we used another model, oral gavage 
model to test bone loss in female and male mice. Female and male mice were orally 
infected with 109 p. gingivalis for 5 times as described in materials and methods. Sham-
infected mice were used as controls. At the extermination of the experiment, we tested 
the CEJ-ABC readings of the female and male mice (Fig 8A). To calculate the bone loss 
value, CEJ-ABC readings of the controls were subtracted from those of experimental 
mice (Fig 8B). The results showed that females developed more bone losses than male 
mice in oral gavage models. 
 
Female macrophages up-regulated more TLR2 expression responding to P. 
gingivalis infection 
 The results in both the ligature and oral gavage models imply that females were 
prone to more severe periodontitis. In order to determine the mechanism and involved 
signaling pathway, we looked into the TLR response of female and male macrophages 
induced by P. gingivalis stimulation. TLRs are important PRRs that recognize PAMP 
from pathogenic bacteria. Fimbriae and LPS from P. gingivalis are important virulent 
factors and act through TLR2 signaling pathway 73. TLR2 is a major receptor for P. 
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gingivalis infection. TLR2 signaling is able to lead to NF-κB activation and induction of 
pro-inflammatory cytokines such as TNFα and IL-6.  The signaling through TLR2 not 
only induces innate immunity, but also promotes adaptive immunity 74. Investigation on 
the TLR2 stimulation in female and male macrophage cells might help us understand the 
differences in inflammation and bone losses. Macrophage cells are one of the most 
important immune cells and are widely investigated for its capability of phagocytosis, 
antigen presentation, and cytokine production. TLR2 expression on macrophage cell 
surface was tested to determine the stimulation through TLRs. After stimulation with P. 
gingivalis, the macrophages expressed higher level of TLR2, implying the stimulation of 
TLR (Fig 9). Furthermore, macrophages from female mice up-regulated more TLR2 than 
males, showing that macrophages from females respond better to P. gingivalis 
stimulation and lead to stronger TLR2 signaling than males (Fig 9).  
 
Female macrophages produce more inflammatory cytokines than male 
macrophages when responding to P. gingivalis infection  
 To understand whether discrepancies in TLR2 response led to different levels of 
inflammation in female and male mice upon P. gingivalis stimulation, we examined pro-
inflammatory cytokine production. Specifically, examining the ability of peritoneal 
macrophage cells in vitro when responding to P. gingivalis stimulation. Peritoneal 
macrophages were isolated from female and male mice, and then stimulated with P. 
gingivalis, and pro-inflammatory cytokines were measured in the supernatants. IL-1β and 
IL-6 were tested for their significant role in periodontitis. As shown in Fig. 10, 
macrophages from both female and male mice all responded well to P. gingivalis 
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stimulation and produced IL-1β and IL-6. Interestingly, female macrophages produced 
significantly higher levels of IL-1β and IL-6 than male macrophages (Fig. 10). IL-1β and 
IL-6 are well known for their detrimental function in PD and bone loss 71. The in vitro 
results match well with gingival cytokine expression in ligature models. This strongly 
implies that by producing more pro-inflammatory cytokines, females might be more 
prone to more severe bone loss and periodontitis.  
Figure 5. Ligation Model Experiment: Periodontal bone loss in ligated female and male 
mice. Mice of 8–10 wk of age were used in the experiment. A ligature was placed around 
the second molar on the left side and infected with P. gingivalis, in three doses. The non-
ligated right side served as the control. The distance (in mm) from the cementoenamel 
junction (CEJ) to the alveolar bone crest (ABC) was measured at 14 predetermined 
maxillary buccal sites, and the readings were totaled for each mouse. Total bone losses 
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Figure 6. Relative expression of cytokines in the gingival tissues. Quantitative real-time 
PCR (qPCR) was used to determine gingival mRNA expression levels for the indicated 
receptors (normalized against GAPDH mRNA levels). The gingivae used were excised 
from either female or male mice (sham-ligated or ligated with P. gingivalis). Results are 
shown as fold induction relative to female sham-ligated mice. Each data point represents 
the mean ± SD of 5 separate expression values, corresponding to qPCR analysis of total 
gingival RNA from individual mice. A minimum of 2-fold difference was a requirement 










Figure 7. Assessment of the number of retrieved anaerobic bacteria from oral cavity of 
female and male mice pre and post-ligation. The swabs were retrieved from oral cavities 
from either female or male mice (pre-ligated or 8 days after ligation with 3 times 
infections of P. gingivalis). Each data point represents the reading from individual mice. 
Asterisks indicate statistically significant differences (p < 0.05) between ligated females 
and males. 




Figure 8A: Oral Gavage Measurements (previous page) 
 
 
Figure 8B: Difference Between Experimental and Control Groups in Oral Gavage 
(above) 
Figure 8A and 8B. Bone losses in female and male mice after oral P.gingivalis infection, 
the oral gavage model. Upper jaw was harvested and both left (L) and right (R) sides 
were measured for CEJ/ABC distance.  The first diagram (8A) provides a mouse-by-
mouse depiction of bone loss readings. Male and female mice that received the bacterium 
infection displayed higher levels of bone loss in comparison to the control (sham) 
infected mice. The second diagram (8B) displays female and male mice vs. bone loss 
(mm change). This was conducted by subtracting the bone loss of the experimental group 
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mice with the sham-infected mice. The female experimental reading was subtracted from 
the female control. Data represented the mean ± SD from 5 mice. (B) Total alveolar bone 
losses in female mice were more than male mice following P.gingivalis infection. 





Figure 9. MFI (Median Fluorescent Intensity) in vitro Study: Female and male 
macrophages expressed up-regulated TLR 2 at different levels post-infection. Peritoneal 
macrophages were harvested from female or male mice. After incubated with 
P.gingivalis with MOI=10, macrophages were stained with TLR2-PE and being analyzed 
by FACS using a FACS-Caliber (BD bioscience). (A) The histograms shown are from 
one of six independent sets of experiments that yielded similar findings. Numbers in the 
histograms are mean fluorescent intensity values. (B) Each data point represents the 
median fluorescence intensity (MFI) of macrophage TLRs from individual mice. 
Asterisks indicate statistically significant (p < 0.05) differences between macrophages 
from female and male mice (n=6). 
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Figure 10. IL-6 and IL-1β cytokine expression following P. gingivalis infection: 
Peritoneal macrophages were harvested from female or male mice. After overnight 
incubation with P.gingivalis with a MOI=10, supernatants were harvested and tested for 
(A) IL-6 and (B) IL-1β secretion by ELISA. Each data point represents the mean value 
(with SD) of cytokine production from individual mice (n= 5).  Asterisks indicate 
statistically significant (p < 0.05) differences between female and male macrophages.




Gender’s role in periodontal disease is controversial due to many extraneous 
variables confounding results75-78. However, studies for the majority show males to be the 
sex predisposed to periodontal disease. Animal models exclude human behaviors and 
variables such as smoking, 12, alcohol consumption 13, and oral hygiene habits, which 
provides a means for examining gender’s true role in this disease. The differences 
amongst females and male mice shed light into the pathogenesis of periodontal disease, 
and are useful in developing models of risk of assessment and economical alternatives for 
future periodontal studies. 
The findings illustrated in our ligature-induced periodontitis model suggested a 
higher degree of periodontitis in female mice, in contrast to their male counterparts. 
These findings were consistent with our cytokine analysis, which revealed the gingival 
tissue of female mice to have significantly elevated expression for pro-inflammatory 
cytokines; p < 0.05; (Fig. 7). The fact that increased CEJ–ABC distances in female mice 
was accompanied by elevated expression of pro-inflammatory cytokines, strongly 
supported periodontal disease among infected female mice. We next looked into 
anaerobic recovery of bacteria. Bacterial colonies were higher amongst female mice.
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 The higher levels of colonies developing within the female mice elucidated to the 
fact that female mice have a better environment for bacterial growth. The rich nutrient 
supply provided by female mice resulted in higher levels of anaerobic biofilms and 
ultimately periodontal disease. The colonies exacerbated the immune system, which in 
turn stimulated the inflammatory response leading to tissue degradation and bone 
resorption. In summary, our findings indicated that the periodontal tissues of female mice 
showed clear signs of increased inflammation and elevated alveolar bone loss compared 
with male mice. 
A follow up experiment, the oral gavage, was conducted for determining the 
validity of the ligature mouse model. This animal model confirmed our results from the 
ligature model. The oral gavage model produced similar results when compared to the 
ligature model.  Our results revealed that female mice are also more susceptible to P. 
gingivalis-induced bone loss in the oral gavage model. (Fig 8) 
To better understand the causes of sexual-dimorphism in periodontitis in animal 
models, an in vitro analysis was carried out to test host responsiveness to P. gingivalis. 
Possible differences in TLR2 expression were investigated in peritoneal macrophages 
from female and male mice. Stimulation of macrophages with P. gingivalis from both 
female and male macrophages displayed significant (p < 0.05) upregulation of Toll-Like 
Receptor 2. This implied that macrophages from females are more responsive to 
P.gingivalis stimulation. Hyper-responsiveness of female cells to pathogens induced 
higher production of pro-inflammatory cytokines, which led to more inflammation and 
bone loss. Indeed, our test on the production of cytokines IL-179 and IL-680, which are 
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important mediators of periodontitis, showed that the macrophages from female mice 
produced higher amounts of these pro-inflammatory cytokines (Fig. 10). 
Males are found to be the gender prone to human periodontal studies 81, which is 
contradictory to what we examined in our mouse model. This inconsistency might be due 
to the fact that periodontitis is a complex disease, which is influenced by many factors. 
There is no single animal model that can represent all the aspects and answer all the 
questions for this disease. However, animal models are still the best tools for mechanism 
studies. These models avoid ethical complications in human research. Various models of 
study can be used, mimicking different aspects of the disease. In this case, the ligature 
model and oral gavage model might not be suitable for research on sexual dimorphism in 
chronic periodontitis, or it may only reflect certain aspect in chronic periodontitis in 
different sexes.  
 It’s worth noting that Baer 25 eluded to the fact that females are 3 times more 
likely to develop aggressive periodontitis than males. Another report 82 concluded that 
aggressive periodontitis, or at least localized juvenile periodontitis, affects females more 
often than males with a ratio of 2.5:1.  We believe our findings, pertaining to the in vivo 
and in vitro studies, can prove useful as an animal model for studying aggressive 
periodontitis amongst males and females. This is a different form disease from chronic 
periodontitis, but serves as a possible direction for our animal model.  
Another direction involves looking into hormones, specifically estrogen. Estrogen 
was reported to increase inflammation levels and cause higher incidences of some 
autoimmue diseases in females 83. Sex hormones play a major role in bone loss, a key 
attribute to periodontal diseases. In periodontal disease, estrogen might cause destruction 
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in several ways. The direct effect of estrogen on bone metabolism is of specific interest, 
and currently under intense investigation. Millions of women develop osteoporosis after 
menopause. Hormone loss after menopause in women is associated with significant bone 
loss, and hormone applications have been used for aged women with osteoporosis. This 
proves hormones are protective for bone loss. The loss of estrogen is reported to induce 
bone loss 84. Reports showed that estrogen is able to directly cause the suppression on 
osteoclast differentiation 85, as well as the apoptosis in osteoclasts 86. Contrarily, the 
protective function of estrogen in bone loss is still not clear. For instance, ovariectomy 
(OVX) before puberty actually promotes bone formation in a mouse model 87. This 
suggests the removal of estrogen is beneficial for bone formation. The function of sex 
hormones in bone loss remains controversial, and obviously isn’t fully understood. These 
discrepancies may be due to the different tissues involved and models of study. Estrogen, 
furthermore, affects the development of immune cells and changes the overall 
environment in host. Estrogen is able to modulate T cells and osteoblasts to synthesize 
cytokines, which are important in bone metabolism. For example, TNF and IL-1 are 
potent osteoclastogenic factors and induce receptor activator for nuclear factor (NF)-κB 
ligand (RANKL) on bone marrow stromal cells and oseteoblasts 88. The essential role of 
RANKL/RANK signaling in osteoclast differentiation is well established, as mentioned 
in the above section on bone resorption.  Loss of estrogen also leads to IL-6 upregulation 
and osteoclast development 89. Estrogen inhibits TNF production by human peripheral 
blood mononuclear cells (PBMCs) in response to LPS stimulation, while enhanceed TNF 
induction without stimulation 90. 
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Estrogen’s function in immunity has never been clarified, because estrogen’s 
function could be dependent on: dosage, the type of immune cells, and the type of 
stimulation.  For example, reports have revealed estrogen to enhance NF-κB in human T 
cells 91, however, observations from other reports have elucidated to the fact the estrogen 
down-regulates NF-κB activation and inflammation in rat astroglial cultures and vascular 
smooth muscle 92, 93. Our future goal is to determine the role of estrogen in sexual 
dimorphism in periodontitis. 
In closing, future directions for experimental work include the role of estrogen in 
periodontal disease. Secondly, Examining this animal model and its correlation to 
aggressive periodontitis. This includes looking at the bacterium Aggregatibacter 
actinomycetemcomitans, a known bacterial component in periodontal disease94. 
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